Skip to main content

Table 1 Patient Description

From: Gel-type autologous chondrocyte (Chondron™) implantation for treatment of articular cartilage defects of the knee

Gender

Male

n (%)

54 (55.1%)

 

Female

n (%)

44 (44.9%)

Age (years)

Mean ± std (Min ~ Max)

43.72 ± 9.10 (17 ~ 65)

 

<30 years

n (%)

10 (10.2%)

 

30~39 years

n (%)

12 (12.2%)

 

40~49 years

n (%)

53 (54.1%)

 

> = 50 years

n (%)

23 (23.5%)

Defect location

Femoral condyle

n (%)

83 (84.7%)

 

Other

n (%)

15 (15.3%)

Defect Size (cm2)

Mean ± std (Min ~ Max)

5.23 ± 2.70 (1.00 ~ 14.50)

 

< 4.0 cm2

n (%)

29 (29.6%)

 

4.0~7.9 cm2

n (%)

57 (58.2%)

 

>8.0 cm2

n (%)

12 (12.2%)

F/u period (Months)

Mean ± std (Min ~ Max)

24.35 ± 8.35 (12~ 52)

 

13~24 Months

n (%)

58 (59.2%)

 

25 Months~

n (%)

40 (40.8%)